Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), announces that the European ...

If the extension indication is granted by the European Commission, Palforzia® will become the first EMA approved oral immunotherapy (OIT) treatment for toddlers living with confirmed peanut allergy.